Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression.

Borsellino, Philip; Krider, Reese I; Chea, Deanna; Grinnell, Ryan; Vida, Thomas A

Borsellino, Philip; Krider, Reese I; Chea, Deanna; Grinnell, Ryan; Vida, Thomas A.

Afiliación

Borsellino P; Kirk Kerkorian School of Medicine at UNLV, 625 Shadow Lane, Las Vegas, NV 89106, USA.
Krider RI; Kirk Kerkorian School of Medicine at UNLV, 625 Shadow Lane, Las Vegas, NV 89106, USA.
Chea D; Kirk Kerkorian School of Medicine at UNLV, 625 Shadow Lane, Las Vegas, NV 89106, USA.
Grinnell R; Kirk Kerkorian School of Medicine at UNLV, 625 Shadow Lane, Las Vegas, NV 89106, USA.
Vida TA; Kirk Kerkorian School of Medicine at UNLV, 625 Shadow Lane, Las Vegas, NV 89106, USA.

Pharmaceuticals (Basel) ; 16(5)2023 May 12.

Article en En | MEDLINE | ID: mdl-37242525

Palabras clave

arketamine; brain-derived growth factor; esketamine; ketamine; major depressive disorder; synaptogenesis; treatment-resistant depression

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google